RSH 11.1% 3.0¢ respiri limited

Value Target for RSH $1.50, page-5

  1. 466 Posts.
    lightbulb Created with Sketch. 213
    Hi Lucasq,
    From my experience with SaaS companies a recurring revenue multiple of 5-10 is fair as they establish themselves, then if they become a key dominant player with a high profit margin, the multiple can easily increase to 15-20x.From memory Dexcom (NASDAQ: DXCM), who has done in diabetes, what we are attempting to do in asthma trades on a revenue multiple of ~20x (DXCM market cap of 22 billion USD)
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
0.003(11.1%)
Mkt cap ! $34.39M
Open High Low Value Volume
2.7¢ 3.0¢ 2.6¢ $14.17K 507.4K

Buyers (Bids)

No. Vol. Price($)
1 17000 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 292869 1
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.